About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Combined Treatment of Treated Bile Duct Cancer | Clinical Trials | Clareo Health

UNKNOWNPhase 2

Combined Treatment of Treated Bile Duct Cancer

Envolizumab in Combination With Sovalteinib for the Treatment of Treated Bile Duct Cancer in an Open, Single-arm, Phase II Clinical Study

NCT05911425•Zhejiang Cancer Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Bile Duct Cancer

Interventions

envolizumab , sovalteinib

Key Dates

Start Date

July 1, 2023

Primary Completion Date

June 30, 2024

Completion Date

June 30, 2025

Last Updated

June 22, 2023

Related Studies

RECRUITINGPhase 2

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Biliary Tract CarcinomaCholangiocarcinoma+1 more

Active Not RecruitingPhase 2

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

NCT05564403

Advanced Biliary Tract CarcinomaAdvanced Gallbladder Carcinoma+15 more

Active Not RecruitingPhase 1

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

NCT04491942

Advanced Bile Duct CarcinomaAdvanced Breast Carcinoma+32 more

Active Not RecruitingNA

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

NCT02293954

Breast CancerColon Cancer+10 more

TERMINATEDPhase 1

A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

NCT05346484

Solid TumorSolid Carcinoma+5 more

The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone

NCT04763642

Pancreatic CancerBile Duct Cancer+1 more

View all related studies

Sponsors

Lead Sponsor

Zhejiang Cancer Hospital

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 22, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions